Similar articles

• Malignant disease of the lymphoid system in immunological perspective.

  Hansen JA, Good RA. Hansen JA, et al. Hum Pathol. 1974 Sep;5(5):567-99. doi: 10.1016/s0046-8177(74)80007-9. Hum Pathol. 1974. PMID: 4137052 Review. No abstract available.
• [Immunological behavior of patients with malignant blood diseases].

  Luca N. Luca N. Stud Cercet Med Interna. 1973;14(5):429-46. Stud Cercet Med Interna. 1973. PMID: 4202394 Review. Romanian. No abstract available.
• [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].

  Berceanu S, Gociu M. Berceanu S, et al. Stud Cercet Med Interna. 1969;10(3):197-208. Stud Cercet Med Interna. 1969. PMID: 4186583 Review. Romanian. No abstract available.
• [T-and B-lymphocytes in lymphoproliferative syndromes].

  Girard JP, Fernandes B. Girard JP, et al. Schweiz Med Wochenschr. 1975 Sep 13;105(37):1174-9. Schweiz Med Wochenschr. 1975. PMID: 814616 French.
• [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].

  Mantovani G, Petrini MT, Tognella S, Grifoni V. Mantovani G, et al. Boll Soc Ital Biol Sper. 1972 Jul 30;48(14):381-5. Boll Soc Ital Biol Sper. 1972. PMID: 4628299 Italian. No abstract available.